Does mirtazapine stimulate appetite?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mirtazapine's Effect on Appetite Stimulation

Yes, mirtazapine does stimulate appetite, which is a well-documented side effect of the medication that can be beneficial in certain clinical scenarios but should not be used solely for appetite stimulation without depression.

Mechanism and Evidence for Appetite Stimulation

Mirtazapine has a strong appetite-stimulating effect that is recognized in multiple clinical guidelines and the FDA drug label:

  • The FDA drug label specifically lists "increased appetite" as a common side effect, occurring in 17% of patients taking mirtazapine compared to only 2% for placebo 1.
  • This appetite stimulation leads to weight gain in approximately 12% of patients taking mirtazapine, compared to 2% for placebo 1.
  • The European Society for Clinical Nutrition and Metabolism (ESPEN) guidelines acknowledge that mirtazapine causes weight gain as a side effect 2.

Clinical Evidence of Weight Gain

The appetite-stimulating effect of mirtazapine translates to measurable weight gain:

  • In a retrospective study of patients with Alzheimer's disease, 77.3% of patients gained weight after 3 months of mirtazapine therapy (mean gain of 1.93 kg or 3.9% of initial body weight) and 82.3% gained weight after 6 months (2.11 kg or 4.6%) 3.
  • The FDA label reports that in U.S. clinical studies, weight gain of ≥7% of body weight was reported in 7.5% of patients treated with mirtazapine, compared to 0% for placebo 1.
  • In pediatric trials, 49% of mirtazapine-treated patients had weight gain of at least 7%, compared to only 5.7% of placebo-treated patients 1.

Appropriate Clinical Use

Despite its appetite-stimulating properties, guidelines recommend specific contexts for mirtazapine use:

  • For patients with depression and poor appetite: Mirtazapine can be beneficial when both conditions are present, as it addresses both issues simultaneously 4.
  • In palliative care settings: Mirtazapine may be useful for anorexia when patients also have sleep difficulties or mood disorders 4.
  • For specific conditions with weight loss: Case reports suggest mirtazapine may help with weight loss associated with conditions like gastroparesis 5.

Important Cautions

Guidelines specifically warn against using mirtazapine solely for appetite stimulation:

  • The ESPEN guideline explicitly states: "Drugs to stimulate appetite or weight gain should NOT be used in persons with dementia" 2.
  • The use of mirtazapine solely for appetite stimulation is not recommended due to potential risks that outweigh uncertain benefits 4.
  • Significant side effects include somnolence (54% vs 18% for placebo), which resulted in discontinuation for 10.4% of patients 1.
  • Other potential risks include QTc prolongation, discontinuation syndrome, and rarely but seriously, agranulocytosis 1.

Monitoring Recommendations

If mirtazapine is used in appropriate clinical scenarios where both depression and poor appetite are present:

  • Monitor for excessive weight gain, as this is a common side effect 4, 1.
  • Watch for sedation, which is the most common adverse effect (54% of patients) 1.
  • Be aware of potential QTc prolongation, especially in patients with cardiovascular disease or taking other QTc-prolonging medications 1.
  • Monitor for rare but serious side effects like agranulocytosis or neutropenia 1.

In conclusion, while mirtazapine definitively stimulates appetite, clinical guidelines recommend against using it solely for this purpose due to its side effect profile. It should be reserved for patients who have both depression and poor appetite, where its dual effect can be beneficial.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Depression with Mirtazapine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Mirtazapine Therapy for a Patient With Weight Loss and Gastroparesis Associated With Limited Systemic Sclerosis.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.